Trials / Completed
CompletedNCT05413824
Neutrophil Side Fluorescent Light (NEU-SFL) in COVID-19 Patients
Neutrophil Side Fluorescent Light (NEU-SFL) in COVID-19 Patients Hospitalized in 2021
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,233 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Nīmes · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Recently, a study showed that markers of neutrophil extracellular traps formation, a mechanism corresponding to neutrophil activation, were increased in patients who died of COVID 19 compared with survivors. The investigators propose to analyze the NEU-SFL parameter, obtained automatically on the Sysmex™ blood count machine (Sysmex Corporation, Kobe, Japan) and which is considered as a reflect of neutrophil extracellular traps formation, in these two groups of patients. The aim was to evaluate whether this parameter could be used to predict the risk of death related to COVID 19.
Conditions
Timeline
- Start date
- 2022-06-02
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2022-06-10
- Last updated
- 2025-12-04
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05413824. Inclusion in this directory is not an endorsement.